Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CDK4 | P11802 | 2/20 | 0.32 |
| ▸ | CCND1 | P24385 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19636228 | 0.84 | KIF11 (0.49) | KIF11KDM4EATML3MBTL1CDK4 | |
| SCHEMBL19636305 | 0.84 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL19213875 | 0.83 | KIF11 (0.49) | KIF11KDM4EATML3MBTL1CDK4 | |
| SCHEMBL21376300 | 0.82 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1HPGD | |
| SCHEMBL21370099 | 0.81 | ESR1 (0.36) | KDM4EATML3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL19041751 | 0.81 | CDK4 (0.40) | KIF11KDM4EATML3MBTL1CDK4 | |
| SCHEMBL24032438 | 0.81 | KDM4E (0.38) | KDM4EATML3MBTL1ALDH1A1HPGD | |
| SCHEMBL16812249 | 0.81 | L3MBTL1 (0.49) | KDM4EATML3MBTL1ALDH1A1HTT | |
| SCHEMBL12196082 | 0.81 | L3MBTL1 (0.51) | KDM4EATML3MBTL1ALDH1A1HPGD | |
| SCHEMBL27048352 | 0.80 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240141-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-27 | — | — | US | disclosed |
| US-20230240141-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-27 | — | — | US | disclosed |
| US-11205755-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2021-12-21 | — | — | US | disclosed |
| WO-2021230650-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-11-18 | — | — | WO | disclosed |
| US-20190189927-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-06-20 | — | — | US | disclosed |
| WO-2018021737-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2018-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240141-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | ESR1, GPX1, LEF1 | KIF11 3100/4885KDM4E 1003/4885ATM 2494/4885 |
| US-11205755-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device thereof | PIEZO1, OR51E2, ORAI2 | KIF11 3407/4885KDM4E 585/4885ATM 3588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.